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Background: Exogenous or endogenous hydrogen peroxide (H2O2) is a reactive oxygen species (ROS) that can
lead to oxidation of cellular nucleophiles, particularly cysteines in proteins. Commercial mouthwashes contain-
ing H2O2 provide the opportunity to determine clinically whether changes in S-glutathionylation of susceptible
proteins in buccal mucosa cells can be used as biomarkers of ROS exposure.
Methods: Using an exploratory clinical protocol, 18 disease-free volunteers rinsed with a mouthwash containing
1.5% H2O2 (442 mM) over four consecutive days. Exfoliated buccal cell samples were collected prior and post-
treatment and proteomics were used to identify S-glutathionylated proteins.
Results: Four consecutive daily treatments with the H2O2-containing mouthwash induced signiﬁcant dose and
time-dependent increases in S-glutathionylation of buccal cell proteins, stable for at least 30min following treat-
ments. Elevated levels of S-glutathionylation were maintained with subsequent daily exposure. Increased S-
glutathionylation preceded and correlated with transcriptional activation of ROS sensitive genes, such as ATF3,
and with the presence of 8-hydroxy deoxyguanosine. Data from a human buccal cell line TR146 were consistent
with the trial results. We identiﬁed twelve proteins that were S-glutathionylated following H2O2 exposure.
Conclusions: Buccal cells can predict exposure to ROS through increased levels of S-glutathionylation of proteins.
These post-translationally modiﬁed proteins serve as biomarkers for the effects of H2O2 in the oral cavity and in
the future,may be adaptable as extrapolatedpharmacodynamic biomarkers for assessing the impact of other sys-
temic drugs that cause ROS and/or impact redox homeostasis.
General signiﬁcance: S-glutathionylation of buccal cell proteins can be used as a quantitativemeasure of exposure
to ROS.
© 2014 Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Hydrogen peroxide (H2O2) is both a chemical toxicant and at lower
concentrations an endogenous physiological signaling molecule [1].
Intracellular concentrations can manifest thresholds that determine
the precise nature of the signal. However, the transmission of the signal-
ing events generally occurs through the oxidation of cellular nucleo-
philes, particularly susceptible cysteine residues that can be found
in certain clusters of target proteins [2]. Emerging evidence conﬁrms
that cellular sensing of redox changes is mediated through post-
translational modiﬁcations (PTMs) of cysteine residues. While there is
debate as to what constitutes redox “sensing” versus redox “signaling”
[3], cysteine residues at various oxidation states are at the center of
the process. Cysteine is one of the least coded amino acids in thetical and Biomedical Sciences,
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icle under the CC BY-NC-ND licensehuman genome (~200,000), implying restricted usage, but evolutionary
importance [4]. S-glutathionylation is a PTM that occurswhen a cysteine
in a low pK environment forms a disulﬁde bondwith glutathione (GSH)
[5,6]. S-glutathionylation is a dynamic and reversible cycle that can
serve as a secondary level of regulation for a number of important cellu-
lar processes in protein cluster functionalities including, kinases and
phosphatases; glycolytic enzymes; calcium transport proteins; cyto-
skeletal structural proteins; protein folding pathways; transcription fac-
tors [7]. S-glutathionylation introduces a negative charge and frequently
alters tertiary and quaternary structure and a variety of protein–protein
interactions [2,6]. S-glutathionylation can serve to protect against fur-
ther oxidative damage and reversal can restore the protein to its native
state [5,7], a circumstance well suited to redox-mediated regulatory
control.
Direct exposure to H2O2 can occur through the use of oral hygiene
and cosmetic tooth whiteners, and commercially available products
can contain concentrations that range from 0.1 to 6.0%. Various reports
have outlined adverse health risks associated with localized effects of
increased cell exposure to reactive oxygen species (ROS; [8,9]). For(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Demographic characteristics of participants.
Demographic variable Number in each category (%)
(n = 18)
Age
Mean (SD) 30.9 (13.3)
18 to 30 years 10 (56%)
31 to 65 years 8 (44%)
Gender
Female 14 (78%)
Male 4 (22%)
Ethnicity
White 11 (62%)
Black 1 (5%)
Native American 1 (5%)
Hispanic 2 (11%)
Asian 3 (17%)
Overall health statusa
High = excellent or very good 7 (39%)
Medium = good 10 (56%)
Low = fair or poor 0 (0%)
Alcohol consumptiona
No 6 (33%)
Occasionally (not consistently) 2 (11%)
1 to 5 drinks/week 6 (33%)
5 to 10 drinks/week 3 (17%)
More than 10 drinks/week 0 (0%)
Smoking habitsa
No 17 (100%)
Yes 0 (0%)
Mouthwash usagea
No 8 (44%)
1 to 3 times/day 8 (44%)
More than 4 times/day 1 (5%)
Currently taking medicationsa
No 11 (61%)
Yes 6 (33%)
Currently taking vitaminsa
No 11 (61%)
Yes 6 (33%)
Recent dental procedures (within last
month)a
No 16 (89%)
Yes 1 (5%) cleaning
a One volunteer declined to answer.
32 C.L. Grek et al. / BBA Clinical 2 (2014) 31–39example, DNA damage in buccal mucosa cells has been associated with
etiology of oral cancers and suggested as a biomarker to assess exposure
to oxidative stress or environmental toxins [10]. Indirect exposure to
H2O2 can occur as a consequence of metabolism of a wide range of
drugs that have electrophilic centers. This is particularly relevant for a
number of anticancer drugs and irradiation.
Recent trends in oncology drug development have moved towards
targeted therapies that allow optimizing treatment for speciﬁc groups
of cancer patients. The application of biomarkers that predict therapy ef-
ﬁcacy and/or toxicity for individual patients andmalignancieswould re-
duce incidence of ineffective treatment protocols and unnecessary side
effects, as well as optimize effective treatments. In diagnosis or progno-
sis of speciﬁc diseases, assessments of matrix combinations of proteins,
nucleic acids ormetabolitesmay in some cases provide the best correla-
tions. However, in measuring drug response, a focused biomarker can
lend itself to quantitative measurements through dose–response stud-
ies. Preclinical studies in mice have suggested that S-glutathionylated
serine protease inhibitors (serpins A1 and A3) in blood could be used
as correlates to drug exposure [11]. Extension of these data to humans
suggested that the evaluation of S-glutathionylated protein proﬁles in
plasma when animals are exposed to agents that cause ROS may pro-
vide useful biomarkers [11]. Collection and monitoring of buccal cells
provides a relatively non-invasive technique to monitor biomarkers
that may assess systemic impact of drug or xenobiotic exposure. It is
challenging to obtain sequential biopsy samples from patients with
solid tumors and as such, surrogate tissues especially blood or cheek
(buccal) cells can provide practical alternatives. To this end we enacted
a clinical trial to consider the predictive value of measuring S-
glutathionylated proteins from buccal cell samples taken from normal
volunteers exposed to H2O2 containing mouthwash. This approach
may prove applicable to pharmacodynamic studies that involve other
drugs or radiation.
2. Participants and methods
2.1. Participants
Eighteen healthy adult (18–75 years old), English-speaking, non-
cognitively impaired volunteers, representative of all races and genders
were recruited at the Medical University of South Carolina between
October 2012 and June 2013. Subjects provided written informed
consent and self reported data on sex, age, race, smoking, dental pro-
cedures, and alcohol consumption are summarized in Table 1.
2.2. Buccal cell collection
The study protocol (Fig. 1) was designed to evaluate the induction of
S-glutathionylation and recovery associatedwith both acute and chron-
ic ROS exposure. Since thiol homeostasis inmammals may be subject to
diurnal variations [12], buccal cells were collected between 10 and
11 a.m. to limit inconsistencies that may be associated to variations in
sensitivity to oxidative stress. Our estimates suggest that, contingent
upon the extent of the ROS exposure (time and concentration effects),
the half-life of S-glutathionylation approximates 3–6 h [13]. This formed
part of the rationale for the timing of sample collection. Because the S-
glutathionylation cycle has a reversible component, longer term sam-
ples to assess the degree of de-glutathionylation were incorporated [2,
14].
Prior to collection participants pre-rinsed the oral cavity with 20mL
deionized (dH2O) water for 2 min, followed by a 1–5 min exposure to
(a) 10 mL dH2O or (b) 10 mL H2O2 (442 mM; 1.5% H2O2) containing
commercial mouthwash (Colgate, New York, USA). Participants
brushed both cheeks vigorously using 20 strokes with a sterile tooth-
brush followed by two-2 min rinses (10mL dH2O). Rinses were collect-
ed in 50 mL tubes and washes were combined and labeled as Wash 1
(W1). After a ‘recovery period’ of 15–30 min 2 washes were repeatedusing a new sterile toothbrush, labeled as Wash 2 (W2). Toothbrushes
were rinsed in their respective washes to recover any further buccal
cells. Complete turnover of buccal epithelium occurs within 5–7 days
[15]. Between all control (collected on Day 1 (D1)) and treatment pro-
tocols (initiating on Day 7 (D7)) a waiting period of 6 days allowed re-
covery and avoided bias towards collection of differentially oxidized cell
populations (cell surface vs. underlying cells) [10,15].
In extended exposure protocols, following an initial buccal cell col-
lection (rinsing with dH2O (Day 1-Wash 1 (D1-W1) and Day 1-Wash
2 (D1-W2))), participants waited 6 days for epithelium recovery and
then began an exposure protocol of two H2O2 mouthwash washes/day
for 2 min. H2O2 rinses were performed between 10–11 AM and 9–
10 PM. Buccal cells were collected following each H2O2 exposure, with
a recovery period of 30 min between W1 and W2. Participants contin-
ued this protocol for 4 days (D7–10) with collections from alternating
cheeks each day (Fig. 1).
Buccal cells were centrifuged (800 ×g for 5 min at 4 °C) and washed
three times (chilled 1× PBS), and the cell pellets were ﬂash frozen and
stored at −80 °C. Unless subject to freeze thawing (not used in this pro-
tocol), our previous experiences suggest that S-glutathionylated proteins
are stable at−80 °C for N2 years. This has been conﬁrmed by others [16].
2.3. Cell culture
The human buccal cell line, TR146 (Sigma-Aldrich, St. Louis, USA)was
maintained at 37 °C and 5% CO2/95% air in 98% humidity, in DMEM
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Fig. 1. Protocol study design.
33C.L. Grek et al. / BBA Clinical 2 (2014) 31–39supplemented with 10% FCS, 100 IU/mL penicillin, and 100 μg/mL
streptomycin. To mimic the growth of cells in the oral cavity,
24,000 cells/cm2were cultured on Falcon®4.2 cm2permeable polyethyl-
ene terephthalate inserts with a pore size of 0.4 μm (Corning, MA, USA)
for 7 days prior to oxidative stress studies. Cells were rinsed twice with
1× PBS prior to H2O2 and ‘recovery periods’ were in the presence of
growth medium.2.4. Protein preparation
Cell pellets were suspended in lysis buffer (20 mM Tris–HCl, pH 7.5,
15mMNaCl, 1mMEDTA, 1mMEGTA, 1% Triton X-100, 2.5mM sodium
pyrophosphate, and 1 mM β-glycerophosphate with freshly added
protease and phosphatase inhibitors, 5 mM NaF and 1 mM Na3VO4)
and incubated for 30 min on ice. Lysates were sonicated for 10 s and
34 C.L. Grek et al. / BBA Clinical 2 (2014) 31–39centrifuged for 30 min at 10,000 g at 4 °C. Protein concentrations were
assayed with Bradford reagent (Bio-Rad Laboratories, Hercules, CA)
using IgG as a standard.
2.5. Immunoblot analysis
Equal amounts of total protein were electrophoretically resolved
under non-reducing conditions on 10% SDS-polyacrylamide gels (SDS-
PAGE); unmodiﬁed proteinswere separated under reducing conditions.
Proteins were transferred onto polyvinylidene diﬂuoride (PVDF) mem-
branes (Bio-Rad, Hercules, CA). Non-speciﬁc binding was reduced in
blocking buffer (20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.1% Tween
20, 1 μM protease inhibitors, 5 mMNaF, and 1 mMNa3VO4) containing
10% non-fat driedmilk, for 1 h.Membranes were incubatedwithmono-
clonal anti-glutathione antibodies (Virogen, Watertown, MA) to detect
protein S-glutathionylation (PSSG), or polyclonal antibodies for actin
or ATF3 (Abcam, Cambridge, MA) in blocking buffer containing 5%
non-fat dried milk overnight at 4 °C, washed 3× with PBS for 15 min,
and incubated with the appropriate secondary antibody (Amersham
Biosciences, Piscataway, NJ) conjugated to horseradish peroxidase for
1 h.Membraneswerewashed 3× and developedwith enhanced chemi-
luminescence detection reagents (Bio-Rad). Blots were scanned with a
BioRad ChemiDoc system and visualized with a transilluminator and
evaluated using Quantity One software (version 4.5.2; Bio-Rad) and
normalized to actin.
2.6. Immunoprecipitation and identiﬁcation of S-glutathionylated proteins
Immunoprecipitations of S-glutathionylated proteins were per-
formed using the anti-glutathione antibody as previously described
[11]. Human buccal cell samples (2 mg) were incubated overnight
at 4 °C with 5 μg of the antibody and separated by non-reducing SDS-
PAGE and bands corresponding to S-glutathionylated proteins were
excised, trypsin digested and analyzed by matrix-assisted laser desorp-
tion/ionization, time-of-ﬂight (MALDI-TOF) mass spectrometry at the
Proteomics Core Facility of the Medical University of South Carolina.
Protein identiﬁcation was performed using software from the National
Center for Biotechnology Information protein database. Automated da-
tabase searching was performed with BioWorks software running
TurboSequest. Accuracy of the peptide assignments was assessed with
Peptide prophet and Protein prophet algorithms from the Institute for
Systems Biology (Seattle, WA). Automated database searching used
GPS Explorer software using Mascot. Only peptides and proteins with
a reported conﬁdence N95% were considered identiﬁed.
2.7 . Cell viability and DNA damage evaluation
TR146 cell viabilitywas evaluated using Trypan Blue solution (Sigma-
Aldrich) and assessing the number of live (translucent) and dead (blue)
cells using a hemocytometer under phase-contrast microscopy. DNA
damage was evaluated using OxiSelect Oxidative DNA ELISA kit (Cell
BioLabs, San Diego, CA) in an ELISA format based on comparison to a
predetermined 8-OHdG standard curve.
2.8. RNA collection and qPCR analyses
Frozen buccal cell pellets were resuspended in 250 μL TE Buffer
(10 mM Tris–HCl, pH 8.0, 10 mM EDTA) containing 200 mM NaOH
and 1% SDS. Pellets were then incubated for 5 min at room temperature
and then 250 μL 3 M potassium acetate, pH 5.5 was added for an addi-
tional 5 min at 4 °C. The supernatant was collected by centrifuging at
18,000 g for 10 min and the RNA processed using the Qiagen RNeasy
kit (Qiagen, Valencia, CA) and stored at −80 °C for future analyses.
cDNA was generated from 2 μg total RNA and real-time PCR (qPCR) re-
actions and data analyses were performed using iQ SYBR Green
Supermix and the MyiQ thermal cycler (Bio-Rad, Hercules, CA)(40 cycles, 58 °C annealing, 81 °C real-time data collection). Each oligo-
nucleotide primer was synthesized by OriGene (Rockville, MD). Results
of experiments were veriﬁed by repetition of RT-PCR with RNA extract-
ed from different aliquots of cells (at least three independent reactions
performed per template/primer combination). For relative quantiﬁca-
tion in qPCR, a mathematical model was used that incorporated the ef-
fects of the efﬁciency of ampliﬁcation for each primer pair over a 104
range of template dilutions and starting template concentrations were
normalized by comparing to β-actin ampliﬁcation. qPCR reactions
were run in triplicate for each sample, and at least three independent
experiments were performed. Overall results were mean of results
from eight individuals' samples.
2.9. Statistical analyses
Statistical analyses were performed in Prism version 5.0 (GraphPad
Software, Inc., San Diego, CA). p values lower than 0.05were considered
signiﬁcant. Differences in the induction of total S-glutathionylation and
ATF3 proteins from participants and cell culture following control or
H2O2 exposure were analyzed by analysis of variance (ANOVA) follow-
ed by a Bonferroni's multiple comparison post-hoc test. For the induc-
tion of S-glutathionylation over time and with increasing doses in
buccal cells in vivo and in TR146 cells, a Dunnett's multiple comparison
post hoc test against baseline controls was used (S1-W1 or 0 H2O2, no
recovery). The induction of 8-OHdG in buccal cells following treatment
with H2O2 was analyzed by ANOVA with a Dunnett's multiple compar-
ison post-hoc test against baseline control (S1-W1). Corrections were
applied based on program recommendations.
3. Results
Oral exposure to 1.5% H2O2 rapidly led to a signiﬁcant increase in S-
glutathionylation of numerous proteins fromhumanbuccal samples rel-
ative to the individual baseline untreated control samples (p b 0.0001,
Fig. 2A–B). S-glutathionylation levels decreased signiﬁcantly (p b 0.01)
after 15 min, but did not return to baseline (p b 0.0001). There were
no signiﬁcant differences in protein S-glutathionylation levels between
initial and recovery samples collected in the control and baseline
samples (Fig. 2B). The sensitivity of the antibodies and the conditions
utilized in the development of the blots likely minimized detection of
S-glutathionylated proteins that were in low abundance. This likely un-
derestimates the basal level of post-translationally modiﬁed proteins in
samples not exposed to H2O2, but these levels are usually quite low.
Basal levels of S-glutathionylation are also dependent on cell and tissue
type. However, a ~40 kDa protein identiﬁed as actin, commonly found
to be S-glutathionylated in the absence of external ROS [2] was present
in baseline samples. Accompanying immunoblots showed signiﬁcant in-
creases in protein levels of the oxidative stress-responsive transcription
factor ATF3 in buccal cells collected 15 min after H2O2 (p b 0.001)
(Fig. 2A–B), conﬁrming that H2O2 activated a general stress associated
transcription factor. Real-time qPCR (Fig. 2C) conﬁrmed that ATF3 was
also transcriptionally upregulated.
S-glutathionylated proteins identiﬁed by MALDI-TOF mass
spectrometry (Table 2) fell into three functional clusters: (a) redox
regulatable enzymes. For example, activities of GSTP1 [14] and various
cysteine dependent serine protease inhibitors [11] have been shown
to be impacted by S-glutathionylation. Inter-α-trypsin inhibitor is one
example of this family [17], but until now there has been no indication
that it is subject to S-glutathionylation. (b) A group of structural pro-
teins inﬂuencing cell shape and motility, also typically subject to
redox regulation [5]. (c) Lactotransferrin, complement and albumin
are cysteine rich proteins known to be subject to this PTM [11]. Given
the sensitivity restrictions of the antibody pull down and detection
methodologies used, it is possible that some less abundant proteins
were not identiﬁed. These proteins represent those that are in S-
glutathionylated at high levels and thus readily detected. Moreover,
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Fig. 2.H2O2 induces protein S-glutathionylation of human buccal cells through stress response pathways. Buccal cells were collected following 5 min oral rinses with dH20 (D1-W1). After
a recovery period of 15min, buccal cells were collected in an additional dH20 wash (D1-W2). After 6 days buccal cells were similarly collected from the same participant following 5 min
oral rinseswith amouthwash containing1.5%H2O2 (D7-W1 andD7-W2). Buccal cell pelletswere lysed and 40 μg proteinwas loaded andevaluated by immunoblot for S-glutathionylation
(PSSG) or ATF3 levels. Actin levelswere usedas loading controls. Representative blots from twoparticipants are shown (panelA). Averaged values and statistical comparisons are shown in
panel B, where fold change is calculated relative to D1-W1. D= day;W= wash; NS= not signiﬁcant; **= p b 0.01; *** = p b 0.001; ****= p b 0.0001; n= 3, ±SD. Panel C shows the
qPCR results for ATF3 samples prepared from eight individuals.
Table 2
MALDI-TOF identiﬁcation of S-glutathionylated buccal cell proteins following H2O2
exposure.
Protein MW
(kDa)
Protein function
GSTP1 24 Phase II metabolism; S-glutathionylation.
Inter-α trypsin
inhibitor
75 Plasma protease inhibitor.
B4GALNT2 20 β-1,4-N-acetyl-galactosaminyl transferase 2
isoform
c; protein glycosylation; negative regulation of cell
adhesion.
GRAF 52 rho GTPase activating protein 26; associates with
focal
adhesion kinase.
PAR6 65 Partitioning defective 6 homolog γ; cell division and
polarization.
Flaggrin 125 Epithelial structure; mucosal S100 fusion type
protein.
Plakoglobin 125 γ-Catenin; complexes with cadherins.
Reticulon-2 65, 20 ER protein promotes membrane curvature,
nuclear pore complex and vesicle formation.
Actin 42 Microﬁlament formation.
Histone H1 20 Chromatin structure.
Lactotransferrin 65 Antimicrobial activity; part of the innate defense at
the mucoses.
Complement 52, 42 Innate immunity.
Albumin 75, 65, 42 Blood globular protein.
35C.L. Grek et al. / BBA Clinical 2 (2014) 31–39while additional peptide fragments were found, the algorithms used in
the proteomic detection procedures prevent identiﬁcation of false
positives.
The S-glutathionylation response was evaluated following chronic
exposure outlined in Fig. 1. Data show that twice daily exposure for
4 days signiﬁcantly potentiated the induction of S-glutathionylation in
buccal cells (Fig. 3A–B) (p b 0.001) as compared to participants' base-
line control samples (D1-W1), in addition to sustaining the time periods
that cells take to recover to basal levels (p b 0.01 at D8 in W2 and
p b 0.001 at D9 and D10 in W2, compared to D1-W1).
As a correlative biomarker of oxidative stress, levels of 8-OHdGwere
measured in the human buccal samples exposed to the chronic H2O2
time course (Fig. 4). In participants completing an extended repeat-
exposure protocol, H2O2 exposure signiﬁcantly increased 8-OHdG levels
by the secondday as compared to the participants' baseline control (D1-
W1) samples (p b 0.001). Signiﬁcantly elevated levels of the damaged
DNA markers were maintained throughout the remainder of the study
(through protocol Day 10) in both initial and recovery (after 30 min)
samples compared to baseline control (D1-W1) (p b 0.001).
TR146 is an immortalized human buccal cell line (isolated from a
neck metastasis) forming undifferentiated, non-keratinized, stratiﬁed
epithelium that shares many morphological and functional characteris-
tics of normal oral mucosa [18,19]. TR146 cells were exposed to increas-
ing concentrations of H2O2 for 2.5min (concentrations of N5% resulted in
signiﬁcant cell death). Immunoblot analyses showed that higher H2O2
concentrations signiﬁcantly increased total protein S-glutathionylation
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Fig. 3.H2O2mediated protein S-glutathionylation and recovery from human buccal cells. H2O2 induced protein S-glutathionylation and recovery in human buccal cells is dose dependent.
Buccal cells were collected following oral rinses for 2 minwith dH20 (D1-W1). After a recovery period of 30min, buccal cells were collected in an additional dH20 wash (D1-W2). Repeat
H2O2 exposure protocolswere initiated 6 days later to allow for oral epithelium recovery. Beginning on Day 7, 2min 1.5% H2O2 treatments were conducted twice daily (in the AMand PM)
to represent habitualmouthwash usage. All sampleswere collected from each participant daily in themorning immediately following treatments (D7-W1; D8-W1;D9-W1;D10-W1) and
then again 30min after exposure (D7-W2; D8-W2; D9-W2; D10-W2). Buccal cell pellets were lysed, and 40 μg total proteinwas loaded and total protein S-glutathionylation (PSSG) levels
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Fig. 4.H2O2 induced DNA damage in human buccal cell samples estimated using 8-OHdG
as amarker. Buccal cellswere collected followingoral rinses for 2minwith dH20 (D1-W1).
After a recovery period of 30 min, buccal cells were collected in an additional dH20 wash
(D1-W2). To allow for oral epithelial recovery, repeat H2O2 exposure protocols were initi-
ated 6 days later. Beginning on Day 7, 2 min 1.5% H2O2 treatments were conducted twice
daily (in the AM and PM) to represent habitual mouthwash usage. All samples were col-
lected from each participant daily in the morning immediately following treatment (D7-
W1; D8-W1; D9-W1; D10-W1) and then again 30 min after exposure (D7-W2; D8-W2;
D9-W2; D10-W2). 8-OHdG levels were calculated against a standard curve. D = day;
W= wash; *** = p b 0.001; n = 3, ±SD.
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Fig. 5A–B). This dose–response plateaus at ~4% H2O2, likely due to satu-
ration or cytotoxicity. Following a 15min recovery, signiﬁcantly elevated
levels of S-glutathionylated proteins remained in all treated samples
compared to untreated controls (1% p b 0.5; 2%–5% p b 0.001). Analyses
of S-glutathionylation levels inmatched samples (immediately following
H2O2 exposure compared to after 15 min recovery) showed that recov-
ery (as a result of deglutathionylation) had not occurred by 15 min
(p N 0.05) and there was a negative correlation with H2O2 dosage
(Fig. 5B). A prominent band corresponding to S-glutathionylated actin
was detected in untreated samples, supportive that the cell model
mimics that of the human data (Fig. 5A).
Treatment of TR146 cells with 1.5% H2O2 yielded a time-dependent
increase in S-glutathionylation that became saturated by 5 min (1 and
2.5 min p b 0.05; 5 and 10 min p b 0.001) as compared to untreated
controls. Following 15 min recovery S-glutathionylation levels were
maintained in cells that had been exposed to 1.5% H2O2 (2.5 min
p b 0.05; 5 min p b 0.01; 10 min p b 0.001). Comparison of protein S-
glutathionylation levels in matched samples (immediately following
H2O2 exposure compared to after 15 min recovery) showed that
signiﬁcant deglutathionylation had not occurred by 15 min (p N 0.05).
Extended exposures to H2O2 mildly increased recovery to baseline S-
glutathionylation levels (Fig. 6A). Treatment of cells with cisplatin did
not induce direct S-glutathionylation (Fig. 6B). However, treatment of
TR146 cells with 2.43 μMcisplatin for 48 h (IC50) potentiated total levels
of (and sustained) S-glutathionylation following H2O2 (p b 0.001) com-
pared to untreated controls. This combination also caused saturation of
S-glutathionylation levels within a min, which was further sustained
and less reversible (Fig. 6A–B). Analyses of matched samples (immedi-
ately following H2O2 compared to 15 min recovery) showed that only
low levels of S-glutathionylation had occurred by 15 min with 1.5%
H2O2 for 2.5, 5 and 10 min (p N 0.05). Cells exposed to 1.5% H2O2 for
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Fig. 5. H2O2 mediated protein S-glutathionylation in TR146 cells is concentration depen-
dent. TR146 cells grown in transwells were treated with various concentrations of H2O2
followed by removal and a recovery period of 15 min. Panel A shows a representative S-
glutathionylation (PSSG) immunoblot. Densitometry levels were normalized to actin
and averaged values and statistical comparisons are shown in panel B, where fold change
is calculated relative to no H2O2. Statistical comparisons of H2O2 induced S-
glutathionylation levels compared to baseline untreated control samples (0% no recovery),
as well as between matched treatments pre- and post-15 min recovery are shown. NS =
not signiﬁcant; * = p b 0.05; *** = p b 0.001; n = 3, ±SD.
37C.L. Grek et al. / BBA Clinical 2 (2014) 31–391 min showed signiﬁcant S-glutathionylation levels during the 15 min
recovery period (p b 0.05) Fig. 6B.
4. Discussion
Aerobic metabolism is themost efﬁcient way to create energy, how-
ever, reactive oxygen species (ROS) such as superoxide (O2•−) and hy-
droxyl radicals (•OH) are byproducts that are non-speciﬁcally reactive
with cellular nucleophiles and can cause toxicity. Exogenous hydrogen
peroxide can be a precursor of these, but it is generally stable (t1/2,
months), can move freely within and between cells and has evolved
as an endogenous second messenger, frequently signaling through
redox regulation of reactive cysteine residues in target proteins [20]. Re-
versible S-glutathionylation of cysteines provides a framework for a
cycle that facilitates such regulation [5]. The biological effects of H2O2
are concentration dependent with a threshold effect that inﬂuences re-
sponse. The present study was designed as an exploratory clinical trial
to consider whether protein S-glutathionylation might be adaptable as
a quantitative/qualitative measure of H2O2 (ROS) exposure. Extrapolat-
ing these results may lead to incorporation of similar biomarkers into
other protocols to monitor pharmacokinetic/dynamic measurements
of other drugs that produce ROS.
The importance of salivary oxidant state has been considered in oral
inﬂammatory diseases and cancer etiology [21]. However, there have
been no studies investigating the impact of ROS on PTM of proteinsfrom buccal cells. In the present trial, the use of the H2O2 mouthwash
rapidly induced both a time- and dose-dependent increase in protein
S-glutathionylation that remained for extended periods. Chronic H2O2
both potentiated induction of S-glutathionylation and extended the pe-
riod of recovery (deglutathionylation). In these samples, H2O2 also en-
hanced expression of ATF3, a transcription factor speciﬁcally linked
with ROS stress response pathways [22]. In addition, H2O2 characteristi-
cally causes nucleic acid damage [23] and our data conﬁrm a dose/time
response for the presence of 8-OHdG in buccal cell samples. Establishing
whether these levels of DNA damage cause precancerous dysplasia,
leukoplakia or oral cancer was beyond the scope of this study. Previous
multi-center, case-controlled studies have reported a link between daily
mouthwash use and head and neck or esophageal cancers; however,
these reports did not consider the relevance of ROS on cell events [24].
H2O2 containing bleaching products have also been associated with
genotoxic effects including micronuclei formation and DNA damage in
buccal mucosa. These have been suggested as biomarkers to assess
ROS exposure or genetic damage in chemoprevention trials [10,
25–27]. However, levels of DNAdamagemaynot always be high enough
to provide a reliablemarker for this type of exposure. In thepresent trial,
our data support linkage between protein S-glutathionylation and DNA
damage in buccal cells.
Proteomic analysis of buccal cell protein S-glutathionylation follow-
ingH2O2 revealed some previously characterized, but a number that are
novel. For example, GSTP1 has been implicated in cancer etiology, drug
resistance, and kinase signaling and can carry out the forward reaction
in the S-glutathionylation cycle [28]. Its activity is subject to auto-
regulation by S-glutathionylation at cysteines 47 and101 [14]. Previous-
ly, altered GST expression was linked with differentiation and tumor
stage in buccal mucosal cancers [29,30], implying a plausible link with
S-glutathionylation. S-glutathionylated plasma protease inhibitors
(serpins A1 and A3), similar to inter-α trypsin inhibitor, not only regu-
latemobilization of bonemarrow progenitor cells [31,32] but also act as
serum biomarkers for exposure to ROS [11]. Speciﬁc protein clusters are
susceptible to S-glutathionylation [2,5] and those identiﬁed here can
be classiﬁed accordingly. For example, structural (B4GALNT2, GRAF,
PAR6, Flaggrin-2, Plakoglobin, Reticulon-2, actin, histone H1), or for
lactotransferrin, complement and albumin, cysteine rich blood proteins
that are sensitive to redox. One (or more) of these S-glutathionylated
proteins may progress as a plausible biomarker for exposure to H2O2
or other ROS. The antibody pull-down techniques used in this study
have some limitations, particularly with regard to sensitivity (for exam-
ple, antibody detection can vary depending on the conformation of the
glutathione adduct and the environment of the thiolated cysteine) and
may have limited the number of S-glutathionylated proteins identiﬁed.
Nevertheless, those proteins shown in Table 2 represent primary S-
glutathionylation targets.
In general terms, buccal cells provide an accessible pool of epithelial
cells that can mirror systemic health status, whether inﬂuenced by ex-
posure to ROS [33] or environmentally genotoxic agents [34,35]. Delete-
rious effects of chemotherapy and radiation can directly manifest in the
oralmucosa, frequently producing compromised epithelial proliferation
and mucosal ulceration [36]. Because a large part of the highly
vascularized mucosa is non-keratinized, exposure of the oral mucosa
to redox altering agents may also leave deeper tissues at risk. Protein
S-glutathionylation is induced in rats, where high levels of protein
bound GSH were detected in squamous cell carcinomas of the tongue
and adjacent tissues [37]. Signiﬁcant levels of S-glutathionylated pro-
teinswere present in the oral cavity long before the presence of clinical-
ly observable lesions implying that theymay serve in the determination
of cancer susceptibility and early etiology.
In parallel with the human clinical trial, we analyzed the effects of
H2O2 in a transformed human buccal cell line. TR146 cells have charac-
teristically high levels of expression of GSTP (data not shown). Induced
and sustained levels of S-glutathionylation in TR146 cells were similar
to those in human buccal cell samples. We compared the results with
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Fig. 6.H2O2 induced protein S-glutathionylation in TR146 cells in buccal cells is time-dependent and cisplatin pretreatment potentiates and sustains S-glutathionylation levels. TR146 cells
grown in transwells were treatedwith 1.5% H2O2 for various time periods followed by removal and a recovery period of 15min without any pretreatment (panel A) or with cell pretreat-
ment for 48 h with 2.43 μM cisplatin (panel B). Representative S-glutathionylation (PSSG) immunoblots are shown in the upper panels. Densitometry levels were normalized to actin and
averaged values and statistical comparisons are shown graphically in the bottom of panels A and B, where fold change is calculated relative to untreated (0min) cells. Statistical compar-
isons of H2O2 induced S-glutathionylation levels as compared to baseline untreated control samples (0 min, no recovery), as well as between matched treatments pre- and post-15 min
recovery are shown. NS=not signiﬁcant; *= p b 0.05; **= p b 0.01; ***= p b 0.001;∝=p b 0.05where signiﬁcant deglutathionylation occurred after a 15min recovery period in cells
treated for 1 min with 1.5% H2O2; n = 4, ±SD.
38 C.L. Grek et al. / BBA Clinical 2 (2014) 31–39cells exposed to cisplatin, a drug known to cause damage to both nucleic
acids and proteins [38]. While cisplatin did not cause signiﬁcant S-
glutathionylation, in combination with H2O2, the drug combination po-
tentiated it and delayed deglutathionylation. Since the platinum
alkylating species [39] do not cause the PTM, some selective degree of
electrophilic selectivity is required.
In the present study, the S-glutathionylation proﬁle of proteins from
buccal cells is predictive of exposure to H2O2. As such, buccal cell
samples should be useful as a surrogate tissue source for biomarker
analysis to deﬁne the effects of speciﬁc drugs that can cause ROS,
enabling development of candidate biomarkers of response to redox-
altering therapeutics. Furthermore, persistent levels of ROS may
activate pro-inﬂammatory events causing toxicity. The identiﬁcation
of biomarkers that evaluate the effects of ROS in the oral cavity may de-
ﬁne at-risk populations for oral cancer and be useful in clinical trials to
measure the efﬁcacy or toxicity of drugs that inﬂuence redox homeosta-
sis. Current efforts validating the prognostic potential of protein S-
glutathionylation proﬁles in large cohorts of patients are currently
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